Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (1): 74-79.doi: 10.3969/j.issn.1000-6621.2019.01.016
• Original Articles • Previous Articles Next Articles
Hui-na WU1,Fu-sheng SUN2(),Qing-wen LIU1,Zhong-lu RONG1,Ji-dong ZHANG1,Yang GAO1,Yong-fu LI1,Fei CHANG1
Received:
2018-11-05
Online:
2019-01-10
Published:
2019-01-09
Hui-na WU,Fu-sheng SUN,Qing-wen LIU,Zhong-lu RONG,Ji-dong ZHANG,Yang GAO,Yong-fu LI,Fei CHANG. The value of fluorescent PCR probe melting curve analysis in detection of Mycobacterium tuberculosis complex for rifa-mpicin and isoniazid resistance[J]. Chinese Journal of Antituberculosis, 2019, 41(1): 74-79. doi: 10.3969/j.issn.1000-6621.2019.01.016
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.01.016
[1] |
Rageade F, Picot N, Blanc-Michaud A , et al. Performance of solid and liquid culture media for the detection of Mycobacterium tuberculosis in clinical materials: meta-analysis of recent studies. Eur J Clin Microbiol Infect Dis, 2014,33(6):867-870.
doi: 10.1007/s10096-014-2105-z URL pmid: 24760249 |
[2] | 赵雁林, 逄宇 . 结核病实验室检验规程.北京: 人民卫生出版社, 2015. |
[3] |
Abbadi SH, Sameaa GA, Morlock G , et al. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Int J Infect Dis, 2009,13(6):673-678.
doi: 10.1016/j.ijid.2008.10.006 URL pmid: 19138546 |
[4] | 王福保, 闵华玲, 叶润修 . 概率论及数理统计. 上海: 上海同济大学出版杜, 1984. |
[5] | Singhal R, Myneedu VP, Arora J , et al. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North-Eastern States of India using GenoType MTBDRplus assay. Indian J Med Res, 2014,140(4):501-506. |
[6] |
Sharma SK, Kohli M, Yadav RN , et al. Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PLoS One, 2015,10(10):e0141011.
doi: 10.1371/journal.pone.0141011 URL pmid: 4619889 |
[7] |
Rahman A, Sahrin M, Afrin S , et al. Comparison of Xpert MTB/RIF assay and GenoType MTBDRplus DNA probes for detection of mutations associated with rifampicin resistance in Mycobacterium tuberculosis. PLoS One, 2016,11(4):e0152694.
doi: 10.1371/journal.pone.0152694 URL pmid: 27054344 |
[8] |
Seifert M, Ajbani K, Georghiou SB , et al. A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 2016,20(5):631-637.
doi: 10.5588/ijtld.15.0788 URL pmid: 27084817 |
[9] | Huang H, Jin Q, Ma Y , et al. Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis (Edinb), 2002,82(2/3):79-83. |
[10] |
Tessema B, Beer J, Emmrich F , et al. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect Dis, 2012,12:37.
doi: 10.1186/1471-2334-12-37 URL pmid: 3378438 |
[11] | Causse M, Ruiz P, Gutierrez JB , et al. New Anyplex ® Ⅱ MTB/MDR/XDR kit for detection of resistance mutations in M.tuberculosis cultures . Int J Tuberc Lung Dis, 2015,19(12):1542-1546. |
[12] |
Jin J, Zhang Y, Fan X , et al. Evaluation of the GenoType ® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection . Int J Tuberc Lung Dis, 2012,16(4):521-526.
doi: 10.5588/ijtld.11.0269 URL pmid: 22325117 |
[13] |
Yadav RN, Singh BK, Sharma SK , et al. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. PLoS One, 2013,8(9):e72036.
doi: 10.1371/journal.pone.0072036 URL pmid: 3764192 |
[14] | 林百丰, 王鑫, 唐鹭 , 等. GeneXpert MTB/RIF检测肺结核患者痰标本的应用价值. 结核病与肺部健康杂志, 2018,7(3):185-187. |
[15] |
Hu S, Li G, Li H , et al. Rapid detection of isoniazid resis-tance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol, 2014,52(5):1644-1652.
doi: 10.1128/JCM.03395-13 |
[16] | 杨新宇, 李波, 赵琰枫 , 等. 564例肺结核患者痰标本质量对检测结果的影响. 结核病与肺部健康杂志, 2018,7(2):109-113. |
[17] |
Huitric E, Werngren J, Juréen P , et al. Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants. Antimicrob Agents Chemother, 2006,50(8):2860-2862.
doi: 10.1109/MIA.2004.1270806 URL |
[18] |
刘宇红, 王甦民, 那希宽 . 比例法测试结核分支杆菌药物敏感性的探讨. 中华结核和呼吸杂志, 2000,23(2):89-92.
doi: 10.3760/j:issn:1001-0939.2000.02.009 URL |
[19] |
Müller B, Borrell S, Rose G , et al. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet, 2013,29(3):160-169.
doi: 10.1016/j.tig.2012.11.005 |
[20] |
柳清云, 孙刚, 高谦 . 结核分枝杆菌(MTB) 异质性耐药研究进展. 复旦学报(医学版), 2013,40(1):1-4.
doi: 10.3969/j.issn.1672-8467.2013.01.001 URL |
[21] | Trauner A, Liu Q, Via LE , et al. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy. Genome Biol, 2017,18(1):71. |
[1] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[2] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[3] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[4] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[5] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[6] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[7] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[8] | Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang. Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354. |
[9] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[10] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[11] | Xue Yu, Yang Xinting, Wang Guirong, Liu Fangchao, Lei Xuan, Zhang Jing, Li Liang. Analysis of risk factors for death in emergency pulmonary tuberculosis patients and risk model construction [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 189-194. |
[12] | Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan. Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209. |
[13] | Liu Ruihua, Sarina , Wang Furong. Interaction between lung cancer and tuberculosis in disease development and progression [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111. |
[14] | Liang Linlong, Pei Yi, Zhou Haiyi, Xie Qifang, Zhang Feng, Jiang Jie, Liu Fuqiang. The epidemiological characteristics and trends of tuberculosis among children aged 0-14 years in Hunan Province from 2014 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 29-35. |
[15] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||